Ghost Tree Capital as of March 31, 2021
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 49 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 11.3 | $48M | 150k | 319.13 | |
| Syndax Pharmaceuticals (SNDX) | 6.2 | $26M | 1.2M | 22.36 | |
| Trillium Therapeutics Com New | 4.9 | $21M | 2.0M | 10.74 | |
| Ark Etf Tr Genomic Rev Etf Put Option (ARKG) | 4.2 | $18M | 200k | 88.73 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 4.1 | $17M | 135k | 128.88 | |
| Kura Oncology (KURA) | 4.0 | $17M | 600k | 28.27 | |
| Iovance Biotherapeutics (IOVA) | 3.7 | $16M | 500k | 31.66 | |
| Fate Therapeutics (FATE) | 3.6 | $15M | 185k | 82.45 | |
| Xenon Pharmaceuticals (XENE) | 3.6 | $15M | 850k | 17.90 | |
| Aclaris Therapeutics (ACRS) | 3.6 | $15M | 600k | 25.20 | |
| Rocket Pharmaceuticals (RCKT) | 3.4 | $14M | 325k | 44.37 | |
| Cogent Biosciences (COGT) | 3.3 | $14M | 1.6M | 8.78 | |
| Arvinas Ord (ARVN) | 3.2 | $14M | 205k | 66.10 | |
| Apellis Pharmaceuticals (APLS) | 2.3 | $9.7M | 225k | 42.91 | |
| Tg Therapeutics (TGTX) | 2.3 | $9.6M | 200k | 48.20 | |
| Vistagen Therapeutics Com New | 2.1 | $8.8M | 4.1M | 2.13 | |
| Mirati Therapeutics | 2.0 | $8.6M | 50k | 171.30 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.8 | $7.9M | 939k | 8.36 | |
| Aldeyra Therapeutics (ALDX) | 1.8 | $7.7M | 650k | 11.88 | |
| Mersana Therapeutics (MRSN) | 1.7 | $7.3M | 450k | 16.18 | |
| Celldex Therapeutics Com New Put Option (CLDX) | 1.7 | $7.2M | 350k | 20.60 | |
| Iveric Bio | 1.6 | $7.0M | 1.1M | 6.18 | |
| Ishares Tr Russell 2000 Etf (IWM) | 1.6 | $6.6M | 30k | 220.93 | |
| Constellation Pharmceticls I | 1.5 | $6.4M | 275k | 23.39 | |
| Biogen Idec (BIIB) | 1.3 | $5.6M | 20k | 279.75 | |
| Satsuma Pharmaceuticals Ord | 1.2 | $5.1M | 904k | 5.68 | |
| Helix Acquisition Corp Com Cl A | 1.2 | $5.1M | 500k | 10.24 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $5.1M | 500k | 10.17 | |
| Essa Pharma Com New (EPIX) | 1.2 | $5.1M | 175k | 29.05 | |
| Catalyst Biosciences Com New | 1.2 | $5.0M | 1.0M | 5.04 | |
| Miragen Therapeutics (VRDN) | 1.2 | $5.0M | 300k | 16.71 | |
| Nuvation Bio Com Cl A (NUVB) | 1.2 | $5.0M | 500k | 9.93 | |
| Curis Com New | 1.1 | $4.8M | 425k | 11.32 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.1 | $4.5M | 150k | 29.87 | |
| Fibrogen (FGEN) | 1.0 | $4.3M | 125k | 34.71 | |
| Immunic (IMUX) | 1.0 | $4.2M | 265k | 15.94 | |
| Immunovant (IMVT) | 0.9 | $4.0M | 250k | 16.04 | |
| Sierra Oncology Com New | 0.8 | $3.4M | 200k | 17.23 | |
| Novavax Com New (NVAX) | 0.7 | $3.2M | 18k | 181.31 | |
| Amicus Therapeutics (FOLD) | 0.6 | $2.6M | 265k | 9.88 | |
| Kadmon Hldgs | 0.5 | $2.3M | 600k | 3.89 | |
| Sage Therapeutics (SAGE) | 0.5 | $2.2M | 30k | 74.87 | |
| Cti Biopharma | 0.5 | $2.2M | 750k | 2.91 | |
| Precision Biosciences Ord | 0.5 | $2.1M | 200k | 10.35 | |
| Chimerix (CMRX) | 0.5 | $1.9M | 200k | 9.64 | |
| Casi Pharmaceuticalsinc Com Stk | 0.4 | $1.6M | 650k | 2.40 | |
| Aptevo Therapeutics Com New | 0.4 | $1.5M | 50k | 30.52 | |
| Otonomy | 0.3 | $1.1M | 450k | 2.55 | |
| Frequency Therapeutics Put Option | 0.2 | $950k | 100k | 9.50 |
